1641 related articles for article (PubMed ID: 20699090)
1. Triglycerides and gallstone formation.
Smelt AH
Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
[TBL] [Abstract][Full Text] [Related]
2. Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil.
Jonkers IJ; Smelt AH; Ledeboer M; Hollum ME; Biemond I; Kuipers F; Stellaard F; Boverhof R; Meinders AE; Lamers CH; Masclee AA
Gut; 2003 Jan; 52(1):109-15. PubMed ID: 12477770
[TBL] [Abstract][Full Text] [Related]
3. [Effect of hypolipidemic treatment on the composition of bile and the risk or cholesterol gallstone disease].
Zák A; Zeman M; Hrubant K; Vecka M; Tvrzická E
Cas Lek Cesk; 2007; 146(1):24-34. PubMed ID: 17310581
[TBL] [Abstract][Full Text] [Related]
4. Role of bile acids and bile acid receptors in metabolic regulation.
Lefebvre P; Cariou B; Lien F; Kuipers F; Staels B
Physiol Rev; 2009 Jan; 89(1):147-91. PubMed ID: 19126757
[TBL] [Abstract][Full Text] [Related]
5. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation.
Watanabe M; Houten SM; Mataki C; Christoffolete MA; Kim BW; Sato H; Messaddeq N; Harney JW; Ezaki O; Kodama T; Schoonjans K; Bianco AC; Auwerx J
Nature; 2006 Jan; 439(7075):484-9. PubMed ID: 16400329
[TBL] [Abstract][Full Text] [Related]
6. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
Julius U
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids.
Davidson MH
Am J Cardiol; 2006 Aug; 98(4A):27i-33i. PubMed ID: 16919514
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and morphological correlations in human gallbladder with reference to membrane permeability.
Hopwood D; Ross PE
Microsc Res Tech; 1997 Sep; 38(6):631-42. PubMed ID: 9330351
[TBL] [Abstract][Full Text] [Related]
9. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit.
Shoda J; He BF; Tanaka N; Matsuzaki Y; Osuga T; Yamamori S; Miyazaki H; Sjövall J
Hepatology; 1995 May; 21(5):1291-302. PubMed ID: 7737634
[TBL] [Abstract][Full Text] [Related]
10. Increased activity of hepatic microsomal triglyceride transfer protein and bile acid synthesis in gallstone disease.
Castro J; Amigo L; Miquel JF; Gälman C; Crovari F; Raddatz A; Zanlungo S; Jalil R; Rudling M; Nervi F
Hepatology; 2007 May; 45(5):1261-6. PubMed ID: 17464999
[TBL] [Abstract][Full Text] [Related]
11. Slow intestinal transit: a motor disorder contributing to cholesterol gallstone formation in the ground squirrel.
Xu QW; Scott RB; Tan DT; Shaffer EA
Hepatology; 1996 Jun; 23(6):1664-72. PubMed ID: 8675191
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of gallbladder emptying decreases cholesterol saturation in bile in the Richardson ground squirrel.
Pauletzki JG; Xu QW; Shaffer EA
Hepatology; 1995 Jul; 22(1):325-31. PubMed ID: 7601426
[TBL] [Abstract][Full Text] [Related]
13. Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism.
Wang S; Sheng F; Zou L; Xiao J; Li P
J Adv Res; 2021 Dec; 34():109-122. PubMed ID: 35024184
[TBL] [Abstract][Full Text] [Related]
14. Fish oil increases bile acid synthesis in male patients with hypertriglyceridemia.
Jonkers IJ; Smelt AH; Princen HM; Kuipers F; Romijn JA; Boverhof R; Masclee AA; Stellaard F
J Nutr; 2006 Apr; 136(4):987-91. PubMed ID: 16549462
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of hepatic microsomal triglyceride transfer protein protects mice from diet-induced gallstones.
Amigo L; Castro J; Miquel JF; Zanlungo S; Young S; Nervi F
Gastroenterology; 2006 Dec; 131(6):1870-8. PubMed ID: 17064699
[TBL] [Abstract][Full Text] [Related]
16. VPAC1 expression is regulated by FXR agonists in the human gallbladder epithelium.
Chignard N; Mergey M; Barbu V; Finzi L; Tiret E; Paul A; Housset C
Hepatology; 2005 Sep; 42(3):549-57. PubMed ID: 16037943
[TBL] [Abstract][Full Text] [Related]
17. Bile acid nuclear receptor FXR and digestive system diseases.
Ding L; Yang L; Wang Z; Huang W
Acta Pharm Sin B; 2015 Mar; 5(2):135-44. PubMed ID: 26579439
[TBL] [Abstract][Full Text] [Related]
18. Effect of the prokinetic agent, erythromycin, in the Richardson ground squirrel model of cholesterol gallstone disease.
Xu QW; Scott RB; Tan DT; Shaffer EA
Hepatology; 1998 Sep; 28(3):613-9. PubMed ID: 9731548
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of triglyceride metabolism in patients with bile acid diarrhea.
Sagar NM; McFarlane M; Nwokolo C; Bardhan KD; Arasaradnam RP
World J Gastroenterol; 2016 Aug; 22(30):6757-63. PubMed ID: 27570415
[TBL] [Abstract][Full Text] [Related]
20. Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia.
Grundy SM
J Clin Invest; 1975 Feb; 55(2):269-82. PubMed ID: 233943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
